Patrick J. Heron, Director at Mirum Pharmaceuticals, Inc. (MIRM), bought 2,910 shares at $28.30 ($82K) on 2023-11-09, disclosed to the SEC on 2023-11-14.
Open-market purchase of $82k MIRM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ARQT | BUY | 2025-06-06 | $30K | — | Filing → |
| ARQT | BUY | 2025-05-23 | $69K | — | Filing → |
| ARQT | BUY | 2025-05-19 | $34K | — | Filing → |